CZIRR JAMES C Insider Trading -- Recent SEC Form 4 Transactions

CZIRR JAMES C (CIK 1260641) reported 28 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-18). Recent activity: Sell GALT (24,000 shares), Sell GALT (30,681 shares), Sell GALT (30,000 shares), Sell GALT (132,069 shares), Sell GALT (30,000 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2025-12-18GALECTIN THERAPEUTICS INC (GALT)InsiderSell24,000$0
2025-12-18GALECTIN THERAPEUTICS INC (GALT)InsiderSell30,681$204,335
2025-12-08GALECTIN THERAPEUTICS INC (GALT)InsiderSell30,000$164,100
2025-12-08GALECTIN THERAPEUTICS INC (GALT)InsiderSell132,069$756,755
2025-12-04GALECTIN THERAPEUTICS INC (GALT)InsiderSell30,000$164,100
2025-12-04GALECTIN THERAPEUTICS INC (GALT)InsiderSell120,000$687,600
2025-11-12GALECTIN THERAPEUTICS INC (GALT)InsiderSell40,000$210,000
2025-10-24GALECTIN THERAPEUTICS INC (GALT)InsiderSell20,000$98,600
2025-10-24GALECTIN THERAPEUTICS INC (GALT)InsiderSell30,000$148,200
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy31,250$27,812
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderSell10,000$0
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy1,000$6,000
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderSell10,000$0
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy46,875$112,031
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy25,000$118,000
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy30,000$85,800
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy40,000$84,400
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy70,000$147,700
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy40,000$79,200
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy40,000$44,400
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderBuy1,000$6,000
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderSell4,400$0
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderSell4,400$0
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderSell4,400$0
2025-06-11GALECTIN THERAPEUTICS INC (GALT)InsiderSell4,400$0

Source: SEC Form 4 filings · as of 2025-12-18